Roche launches new process for accessing clinical trial data
26 February 2013 | By Roche
Independent body to grant access to patient-level data for scientific review...
List view / Grid view
News
AstraZeneca announces results from long-term safety trial of naloxegol in patients with opioid-induced constipation
26 February 2013 | By AstraZeneca
AstraZeneca announced high-level results from KODIAC-08...
Novartis reports Phase III data showing omalizumab improved itch in patients with a chronic form of hives who failed standard therapy[1]
24 February 2013 | By Novartis
Late-breaking results from ASTERIA II...
Phase III results: tiotropium* Respimat® is effective in symptomatic asthma patients irrespective of their allergic status
23 February 2013 | By Boehringer Ingelheim
New Phase III data presented...
European Medicines Agency recommends approval of Hexyon/Hexacima 6-in-1 pediatric vaccine
22 February 2013 | By Sanofi
The EMA recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine...
FDA approves Roche’s Kadcyla (trastuzumab emtansine)
22 February 2013 | By Roche
New personalised medicine helped people in Phase III study live longer, compared to standard treatment...
Tecan microarray solutions transform functional proteomics workflows at ASU
21 February 2013 | By kdm communications
“We have adopted a unique approach to functional proteomics..."
ARIAD announces appointment of European General Manager and other key members of leadership team
21 February 2013 | By Biosector 2
ARIAD announced the appointment of Jonathan E. Dickinson...
New findings from two studies support substantial benefit of Pradaxa® for prevention of recurrent deep vein thrombosis and pulmonary embolism
21 February 2013 | By Boehringer Ingelheim
Findings from two trials...
Abbott to collaborate with Janssen and Pharmacyclics
21 February 2013 | By Abbott
Abbott will collaborate with Janssen Biotech and Pharmacyclics to explore the benefits of Abbott's proprietary FISH technology...
Announcement of application for approval in Japan of DPT-IPV vaccine
20 February 2013 | By Daiichi Sankyo
DPT-IPV vaccine for prevention of Diphtheria, Pertussis, Tetanus, and acute Poliomyelitis...
Phase 3 data shows bendamustine plus rituximab doubles progression-free survival in patients with iNHL and MCL compared with CHOP-R
Results from the StiL NHL-1 study...
Merck and Samsung Bioepis enter biosimilars development and commercialization agreement
20 February 2013 | By Merck
Merck and Samsung Bioepis Co., Ltd., entered into an agreement...
Gilead and Teva reach settlement agreement in Viread ® patent litigation
19 February 2013 | By Gilead Sciences
Gilead and Teva Pharmaceuticals have reached an agreement in principle to settle the ongoing patent litigation...
Shire’s VPRIV® wins first ever “Novel Treatment Award”
19 February 2013 | By Edelman on behalf of Shire
"Shire has demonstrated its commitment to developing new therapies for the treatment of rare genetic diseases..."
